Thiel Capital’s Jason Camm Discusses Joining Psychedelics Company ATAI Following $24 Million Raise

August 25, 2020 Articles 7:21 pm

A couple days ago, ATAI Life Sciences, a biotech company developing psychedelic medicines for a variety of mental health indication, announced that it had raised $24 million in a convertible note financing round.

 

JOIN THE ATAI #INSIGHTNETWORK

Receive the latest news on ATAI and innovations in the space.

Email
submit